Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
38
+2
+6% +$526 0.01% 425
2026
Q1
$9.61K Buy
36
+4
+13% +$1.08K 0.01% 450
2025
Q4
$8.03K Sell
32
-9
-22% -$2.39K ﹤0.01% 447
2025
Q3
$11.8K Buy
41
+8
+24% +$2.14K ﹤0.01% 433
2025
Q2
$8.66K Sell
33
-7
-18% -$1.71K ﹤0.01% 474
2025
Q1
$9.31K Hold
40
﹤0.01% 440
2024
Q4
$9.17K Buy
40
+5
+14% +$1.15K ﹤0.01% 462
2024
Q3
$7.82K Hold
35
﹤0.01% 526
2024
Q2
$7.46K Sell
35
-5
-13% -$1.02K ﹤0.01% 508
2024
Q1
$9.09K Hold
40
﹤0.01% 428
2023
Q4
$9.09K Buy
+40
New +$8.4K ﹤0.01% 428

Other funds holding LH

Sachetta's LH Position: Q2 2026 in Review

Sachetta increased its Labcorp (LH) stake by 5.6% in Q2 2026, buying an estimated $526 and bringing the position to 38 shares worth $10.6K. The position accounts for 0.01% of the portfolio, ranked #425.

Sachetta first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.8K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Sachetta held 38 shares of Labcorp worth $10.6K as of Q2 2026.
  • Sachetta bought 2 Labcorp shares in Q2 2026, an estimated $526.
  • Labcorp made up 0.01% of Sachetta's portfolio in Q2 2026, its #425 holding.
  • Sachetta first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Labcorp position peaked at $11.8K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.